Search results
Results from the WOW.Com Content Network
Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, India.It was founded by Kiran Mazumdar-Shaw in 1978. [4] The company manufactures generic active pharmaceutical ingredients (APIs) that are sold in approximately 120 countries, [5] including the United States and Europe. [4]
In February 2022, Viatris announced an agreement where it will contribute to Biocon Biologics its biosimilars portfolio and related commercial and operational capabilities in exchange for up to $3.335 billion, including a stake of at least 12.9% in Biocon Biologics. [11] The transaction was completed in November 2022. [12]
The main effect of stock splits is an increase in the liquidity of a stock: [3] there are more buyers and sellers for 10 shares at $10 than 1 share at $100. Some companies avoid a stock split to obtain the opposite strategy: by refusing to split the stock and keeping the price high, they reduce trading volume.
Mylan assumes the rights to develop and market three of Biocon's products - generic drugs Glargine, Lispro, and Aspart - while the two companies will share development and other costs.
Big-name stocks that have split their shares in recent years have generally done fairly well afterward.
For premium support please call: 800-290-4726 more ways to reach us
D – New issue or reverse split N – third class – preferred shares X – Mutual fund: E – Delinquent SEC filings: O – second class – preferred shares Y – American depositary receipt (ADR) F – Foreign P – first class preferred shares Z – Miscellaneous situations G – first convertible bond: Q – In bankruptcy: Special codes
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!